Article Contents ::
- 1 Details About Generic Salt :: Omeprazo
- 2 Main Medicine Class:: GI
- 3 (oh-MEH-pray-ZAHL) Prilosec Capsules, delayed-release: 10 mg Capsules, delayed-release: 20 mg Capsules, delayed-release: 40 mg Losec Class: GI
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Omeprazo
Main Medicine Class:: GI
(oh-MEH-pray-ZAHL)
Prilosec
Capsules, delayed-release: 10 mg
Capsules, delayed-release: 20 mg
Capsules, delayed-release: 40 mg
Losec
Class: GI
Drugs Class ::
Action Suppresses gastric acid secretion by blocking “acid (proton) pump” within gastric parietal cell.
Indications for Drugs ::
Indications Short-term treatment of active duodenal ulcer, gastroesophageal reflux disease (GERD), including erosive esophagitis and symptomatic GERD; long-term treatment of pathologic hypersecretory conditions (eg, Zollinger-Ellison syndrome, multiple endocrine adenomas, systemic mastocytosis); to maintain healing of erosive esophagitis; in combination with clarithromycin to eradicate H. pylori, use clarithromycin and amoxicillin in combination with omeprazole in patients with a 1-yr history of duodenal ulcers or active duodenal ulcers to eradicate H. pylori ; short-term treatment of active benign gastric ulcer.
Posterior laryngitis; enhanced efficacy of pancreatin for treatment of steatorrhea in cystic fibrosis.
Drug Dose ::
Route/Dosage
Active Duodenal Ulcer
Adults: PO 20 mg/day for 4 to 8 wk.
Erosive Esophagitis
Adults: PO 20 mg/day for 4 to 8 wk. Maintenance: 20 mg/day.
Pathologic Hypersecretory Conditions
Adults: PO Initial dose: 60 mg/day. Doses up to 120 mg tid have been given. Divide daily doses more then 80 mg.
H. pylori
Adults (triple therapy): PO 20 mg omeprazole plus clarithromycin 500 mg plus amoxicillin 1000 mg each given bid for 10 days; continue omeprazole 20 mg/day for an additional 18 days if an ulcer is present at start of therapy. Adults (dual therapy): PO 40 mg omeprazole once daily plus clarithromycin 500 mg tid for 14 days; continue omeprazole 20 mg/day for an additional 14 days if an ulcer is present at start of therapy.
Gastric ulcer
Adults: PO 40 mg once daily for 4 to 8 wk.
GERD
Adults (without esophageal lesions): PO 20 mg/day for 4 wk. Adults (with erosive esophagitis): PO 20 mg/day for 4 to 8 wk.
Contraindication ::
Contraindications Standard considerations.
Drug Precautions ::
Precautions
Pregnancy: Category C. Lactation: Undetermined. Children: Safety and efficacy in children not established.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CARDIOVASCULAR: Angina; tachycardia; bradycardia; palpitation. CNS: Headache; dizziness. DERMATOLOGIC: Rash. GI: Diarrhea; abdominal pain; acid regurgitation; nausea; vomiting; constipation; flatulence. RESPIRATORY: Cough; upper respiratory tract infection. OTHER: Asthenia; back pain.
Drug Mode of Action ::
Action Suppresses gastric acid secretion by blocking “acid (proton) pump” within gastric parietal cell.
Drug Interactions ::
Interactions
Benzodiazepines: Clearance of benzodiazepines may be decreased. Cilostazol: Plasma levels may be increased by omeprazole, increasing the therapeutic and adverse effects. Clarithromycin: Serum concentrations of clarithromycin and omeprazole may be increased. Drugs depending on gastric pH for bioavailability (eg, ketoconazole, iron salts, ampicillin): Absorption of these drugs may be affected. Phenytoin: Decreased plasma clearance and increased phenytoin half-life. Warfarin: Prolonged warfarin elimination.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any known allergies.
- Review baseline CBC and LFT results, and monitor as indicated.
- Assess for coffee ground emesis, tarry stools, or constipation.
- Assess for any symptoms of hyperacidity (eg, dyspepsia, nausea, vomiting).
- Monitor elimination patterns and document any problems such as constipation.
- Assess skin for rashes or hives.
- Encourage adequate fluid intake and roughage in diet.
|
Drug Storage/Management ::
Administration/Storage
- Do not open, chew, or crush capsule. Instruct patient to swallow capsule whole.
- Divide daily doses greater than 80 mg.
- Give before meals or as one-time daily dose. If medication is administered once daily, give before dinner.
- Store at room temperature in original container tightly closed and protected from light.
Drug Notes ::
Patient/Family Education
- Advise patient not to chew or crush medication, and to swallow medication whole.
- Remind patient to take medication before meals.
- Inform patient that antacids may be taken concurrently with omeprazole.
- Advise patient to avoid tasks requiring alertness until response to medication is established.
- Caution patient to report the following symptoms to health care provider: cramping, diarrhea, rash, hives.